Srikanth Sathyanarayan

Associate Manager at Biocon Biologics India Limited

Role: Associate Manager at Biocon Biologics
Location: Bengaluru, KA, IN
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

About Srikanth Sathyanarayan

Involved in Manufacturing support, scale up, technology transfer, Cost reduction…

Experience

Associate Manager
Biocon Biologics
Jul 2019 — Present
OOS OOT Investigation, Trouble shooting Process monitoring, Self inspection, Lab management, Employee training, Training Coordinator

Education

Bangalore University
M.Sc
2004 — 2006
Bangalore University
Bachelor Of Science
2001 — 2004

Skills

Proteomics
Sds-Page
Immunoassays
Electrophoresis
Purification
Protein Expression
Glp
Cell
Elisa
Biotechnology
Protein Purification
Biopharmaceuticals
Drug Discovery
Chromatography
Downstream Processing
Monoclonal Antibodies
Assay Development
Crystallization
Technology Transfer
Technical Training
Protein Chemistry
Cell Culture
Antibodies
Hplc
Enzyme Assays
Biochemistry
Gmp

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@bioconbiologics.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Biocon Biologics

Biotechnology Research · 5.4K employees · Founded 1978 · Bengaluru, India

Fraudulent Recruitment Advisory: Biocon and its subsidiaries never charge candidates any fee at any stage of recruitment. Learn how to identify and report fraudulent job offers: https://www.bioconbiologics.com/fraudulent-recruitment-advisory/ Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics

bioconbiologics.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.